4.6 Review

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Oncology

Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism

Ling-Yan Cai et al.

Summary: This study demonstrates p300/CBP as a critical epigenetic regulator of glycolysis-related metabolic enzymes in HCC and identifies the p300/CBP inhibitor B029-2 as a potential therapeutic strategy in this disease.

CANCER RESEARCH (2021)

Article Biochemistry & Molecular Biology

Acquired deficiency of peroxisomal dicarboxylic acid catabolism is a metabolic vulnerability in hepatoblastoma

Huabo Wang et al.

Summary: Metabolic reprogramming in transformed cells provides them with proliferative and survival advantages, but therapeutic applications have been limited by small differences in metabolic pathways and cancer adaptation. However, experiments have shown that downregulation of Ehhadh in hepatoblastoma makes them more susceptible to dietary intervention with C12, leading to longer survival and potential resistance development. This research suggests the feasibility of non-toxic dietary supplementation with C12 or DDDA, which may be compatible with standard chemotherapies.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Cell Biology

HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α

Nanmu Yang et al.

Summary: HBXIP drives metabolic reprogramming in HCC cells via METTL3-mediated m6A modification of HIF-1 alpha.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Biochemistry & Molecular Biology

C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism

Yu Zhang et al.

Summary: Chronic hepatitis B virus (HBV) infection is strongly linked to hepatocellular carcinoma (HCC) development. Genetic alterations and molecular mechanisms, especially HBV-induced metabolic reprogramming, are still underexplored. This study reveals the role of Ct-HBx in HCC progression through downregulation of TXNIP and suggests TXNIP as a potential therapeutic target in treating HCC.

ONCOGENE (2021)

Review Oncology

Advances in systemic therapy for the first-line treatment of unresectable HCC

Arndt Vogel et al.

Summary: Hepatocellular carcinoma is a common and deadly cancer worldwide. Multiple phase-III trials are currently focusing on combination therapies of checkpoint inhibitors, tyrosine kinase inhibitors, and anti-angiogenic antibodies as potential first-line treatments. Experts believe that immuno-oncology-based combination therapies will likely become the standard of care in frontline therapy for HCC, with their potent anti-tumor efficacy and good tolerability.

EXPERT REVIEW OF ANTICANCER THERAPY (2021)

Article Gastroenterology & Hepatology

Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species

Derek Lee et al.

Summary: This study reveals the distinct regulatory mechanisms of malic enzymes ME1 and ME3 in hepatocellular carcinoma (HCC), with ME1 being controlled by the NRF2-mediated oxidative stress response pathway and ME3 being constitutively induced by superenhancers. Disrupting these regulatory pathways can slow down HCC progression, and targeting both mechanisms may present a potential therapeutic approach for HCC treatment.

HEPATOLOGY (2021)

Review Cell Biology

The mTOR-Autophagy Axis and the Control of Metabolism

Nerea Deleyto-Seldas et al.

Summary: mTOR is a master regulator of cellular metabolism, existing in two distinct complexes. mTORC1 plays a key role in cell growth and biomass establishment, while mTORC2 is closely related to mTORC1. mTOR inhibits autophagy through multiple mechanisms, including the inhibition of early autophagic processes and the control of lysosomal degradative capacity.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Biochemistry & Molecular Biology

Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target

David B. Pirovich et al.

Summary: Fructose 1,6-bisphosphate aldolase is a ubiquitous cytosolic enzyme that plays a key role in carbohydrate metabolism, as well as carries out non-enzymatic functions; it has been found on the extracellular surface of pathogens and parasites, contributing to virulence enhancement.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Review Gastroenterology & Hepatology

Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma

Bruno Sangro et al.

JOURNAL OF HEPATOLOGY (2020)

Review Biochemistry & Molecular Biology

Autophagy and autophagy-related proteins in cancer

Xiaohua Li et al.

MOLECULAR CANCER (2020)

Article Oncology

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma

Sean P. Martin et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

Mechanisms of replication and repair in mitochondrial DNA deletion formation

Gabriele A. Fontana et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Immunology

Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Medicine, General & Internal

Hepatocellular Carcinoma

Augusto Villanueva

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Biochemistry & Molecular Biology

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

Qiang Gao et al.

Article Immunology

Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance

Xiaohu Zheng et al.

NATURE IMMUNOLOGY (2019)

Review Immunology

The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy

Fernando Souza-Fonseca-Guimaraes et al.

TRENDS IN IMMUNOLOGY (2019)

Review Immunology

NK Cell Metabolism and TGFβ - Implications for Immunotherapy

Karen Slattery et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

EGFR-Phosphorylated Platelet Isoform of Phosphofructokinase 1 Promotes PI3K Activation

Jong-Ho Lee et al.

MOLECULAR CELL (2018)

Review Biochemistry & Molecular Biology

Mitochondrial-dynamics-in-cancer-induced-cachexia

Miranda van der Ende et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Review Cell Biology

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

Serena De Matteis et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)

Article Immunology

Adenosinergic Signaling Alters Natural Killer Cell Functional Responses

Andrea M. Chambers et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

mTORC1 as the main gateway to autophagy

Yoana Rabanal-Ruiz et al.

SIGNALLING MECHANISMS IN AUTOPHAGY (2017)

Review Cell Biology

Metabolic Interactions in the Tumor Microenvironment

Costas A. Lyssiotis et al.

TRENDS IN CELL BIOLOGY (2017)

Article Multidisciplinary Sciences

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

Orianne Olivares et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis

Ewelina Krzywinska et al.

NATURE COMMUNICATIONS (2017)

Review Nutrition & Dietetics

The Macronutrients, Appetite, and Energy Intake

Alicia L. Carreiro et al.

ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)

Review Pharmacology & Pharmacy

The Warburg effect and drug resistance

Bhaskar Bhattacharya et al.

BRITISH JOURNAL OF PHARMACOLOGY (2016)

Article Biochemistry & Molecular Biology

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming

Michael D. Buck et al.

Review Cell Biology

The Emerging Hallmarks of Cancer Metabolism

Natalya N. Pavlova et al.

CELL METABOLISM (2016)

Article Immunology

Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells

Sinead E. Keating et al.

JOURNAL OF IMMUNOLOGY (2016)

Review Biochemistry & Molecular Biology

The Warburg Effect: How Does it Benefit Cancer Cells?

Maria V. Liberti et al.

TRENDS IN BIOCHEMICAL SCIENCES (2016)

Article Oncology

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Suzanne L. Topalian et al.

CANCER CELL (2015)

Article Immunology

Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells

Pamela M. Odorizzi et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Immunology

mTORC1-Dependent Metabolic Reprogramming Is a Prerequisite for NK Cell Effector Function

Raymond P. Donnelly et al.

JOURNAL OF IMMUNOLOGY (2014)

Article Multidisciplinary Sciences

Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides

Kivanc Birsoy et al.

NATURE (2014)

Article Multidisciplinary Sciences

mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity

Shih-Chin Cheng et al.

SCIENCE (2014)

Review Biochemistry & Molecular Biology

The pentose phosphate pathway and cancer

Krushna C. Patra et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Article Multidisciplinary Sciences

A dual role for autophagy in a murine model of lung cancer

Shuan Rao et al.

NATURE COMMUNICATIONS (2014)

Article Biochemistry & Molecular Biology

Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy

Yoshinobu Ichimura et al.

MOLECULAR CELL (2013)

Review Biotechnology & Applied Microbiology

Modulation of oxidative stress as an anticancer strategy

Chiara Gorrini et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Review Gastroenterology & Hepatology

Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis

Francesca Guerrieri et al.

SEMINARS IN LIVER DISEASE (2013)

Article Gastroenterology & Hepatology

Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma

Chia-Chi Hsu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Review Chemistry, Medicinal

Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors

Yan Xia et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou et al.

NATURE CHEMICAL BIOLOGY (2012)

Article Oncology

Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release

Kristina Goetze et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2011)

Review Oncology

Otto Warburg's contributions to current concepts of cancer metabolism

Willem H. Koppenol et al.

NATURE REVIEWS CANCER (2011)

Article Multidisciplinary Sciences

HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

Charles J. David et al.

NATURE (2010)

Article Biochemistry & Molecular Biology

Autophagy Suppresses Tumorigenesis through Elimination of p62

Robin Mathew et al.

Article Biochemistry & Molecular Biology

Cancer cell metabolism: Warburg and beyond

Peggy P. Hsu et al.

Article Biochemistry & Molecular Biology

Mitochondrial O2-• and H2O2 mediate glucose deprivation-induced cytotoxicity and oxidative stress in human cancer cells

IM Ahmad et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Biochemistry & Molecular Biology

Ras is involved in the negative control of autophagy through the class IPI3-kinase

S Furuta et al.

ONCOGENE (2004)